@article{90cacfb2d46841a283acf9a408e31887,
title = "Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?",
keywords = "Adjuvant therapy, Breast cancer, Economic evaluation, T1Bn0, Trastuzumab",
author = "C. Skedgel and D. Rayson and T. Younis",
note = "Funding Information: This work was supported by the Beatrice Hunter Cancer Research Institute, with funding from the Breast Cancer Society of Canada and the Queen Elizabeth II Foundation Award for breast cancer research. Grant number at CDHA for finances. Account 1010777 SAP 691883.",
year = "2013",
month = jul,
doi = "10.1093/annonc/mdt069",
language = "English",
volume = "24",
pages = "1834--1840",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "7",
}
